** Shares of Next Science NXS.AX rise as much as 6.6% to
A$0.565
** Stock on track for highest intraday gain since June 1 if
trends hold
** Co says it has appointed Harry Thomas Hall IV as Managing
Director and CEO
** Says Hall IV has held various roles in the global medical
device industry
** Co says it is focusing on commercialising its XBIO
technology which aims to reduce the impact of biofilm-based
infections
** Says outgoing CEO Judith Mitchell will remain with co
until the end of July to aid in a smooth handover
** Stock down 22.6% YTD, as of last close
(Reporting by Riya Sharma in Bengaluru)
((Riya.Sharma@thomsonreuters.com;))